Perspective Therapeutics Inc (CATX) Options Open Interest

Monitoring CATX open interest helps you see where real money is positioned on Perspective Therapeutics Inc's options and which strikes are attracting the most commitment from traders. Perspective Therapeutics Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor CATX options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising CATX options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect Perspective Therapeutics Inc to settle.

Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc.

in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where CATX open interest is concentrated. Our scanner maps Perspective Therapeutics Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade Perspective Therapeutics Inc's options open interest as the signal it is, not as an afterthought.